Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Nab-paclitaxel as first line treatment of gastrointestinal neuroendocrine carcinomas shows efficacious results

Dr Lorraine Chantrill - University of Sydney, Sydney, Australia
Nab-paclitaxel as first line treatment of gastrointestinal neuroendocrine carcinomas shows efficacious results ( Dr Lorraine Chantrill - University of Sydney, Sydney, Australia )
9 Feb 2024

Trifluridine/tipiracil and bevacizumab combination gives a prolonged PFS compared to trifluridine/tipiracil monotherapy in mCRC

Prof Hironaga Satake - Kochi Medical School, Kochi, Japan
Trifluridine/tipiracil and bevacizumab combination gives a prolonged PFS compared to trifluridine/tipiracil monotherapy in mCRC ( Prof Hironaga Satake - Kochi Medical School, Kochi, Japan )
8 Feb 2024

Combination of cabozantinib and atezolizumab shows moderate activity in treating metastatic adrenocortical carcinoma

Dr Enrique Grande - MD Anderson Cancer Center Madrid, Madrid, Spain
Combination of cabozantinib and atezolizumab shows moderate activity in treating metastatic adrenocortical carcinoma ( Dr Enrique Grande - MD Anderson Cancer Center Madrid, Madrid, Spain )
30 Jan 2024

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC

Dr Thierry André - Sorbonne Université, Paris, France
Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC ( Dr Thierry André - Sorbonne Université, Paris, France )
24 Jan 2024

Gastro-intestinal endoscopy capacity in Nigeria: strengths and challenges

Prof Olusegun Alatise - Obafemi Awolowo University, Ife, Nigeria
Gastro-intestinal endoscopy capacity in Nigeria: strengths and challenges ( Prof Olusegun Alatise - Obafemi Awolowo University, Ife, Nigeria )
19 Jan 2024

Colorectal cancer risk factors in Nigeria

Prof Olusegun Alatise - Obafemi Awolowo University, Ife, Nigeria
Colorectal cancer risk factors in Nigeria ( Prof Olusegun Alatise - Obafemi Awolowo University, Ife, Nigeria )
19 Jan 2024

ESMO 2023: Highlights and analysis

Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2023: Highlights and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
8 Nov 2023

GI cancers

Dr Tanvi Sood - Paras hospital, Gurugram, India
GI cancers ( Dr Tanvi Sood - Paras hospital, Gurugram, India )
7 Nov 2023

Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery

Dr Berend Van der Wilk - Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery ( Dr Berend Van der Wilk - Erasmus MC Cancer Institute, Rotterdam, The Netherlands )
23 Oct 2023

Sotorasib and panitumumab demonstrate clinically meaningful benefit in KRAS G12C-mutated metastatic colorectal cancer 

Dr Filippo Pietrantonio - ‎The National Cancer Institute of Milan, Milan, Italy
Sotorasib and panitumumab demonstrate clinically meaningful benefit in KRAS G12C-mutated metastatic colorectal cancer  ( Dr Filippo Pietrantonio - ‎The National Cancer Institute of Milan, Milan, Italy )
23 Oct 2023

Management of surgical complications in thyroid surgery

Dr Kapila Manikantan - Tata Medical Center, Kolkata,India
Management of surgical complications in thyroid surgery ( Dr Kapila Manikantan - Tata Medical Center, Kolkata,India )
9 Oct 2023

OncoAlert Round Up for August 25th - 31st, 2023

Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for August 25th - 31st, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
4 Sep 2023